Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Cardiol Young ; 31(5): 865-866, 2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-33568249

RESUMO

Kawasaki disease is an acute systemic vascular disease, generally self-limited and typically affecting children <5 years old, which leads to coronary artery aneurysms in about 25% of untreated cases. Cardiovascular involvement is characterised by transient pancarditis, in acute phase, while coronary illness, ranging from mild dilation to giant CAAs occurs late, rarely before the 10th day since fever onset. Here, we describe a peculiar case of KD, which occurred in a 4-month-old infant and presented with exudate cardiac tamponade and early giant aneurism of both the proximal right coronary artery) and the left circumflex coronary artery, in acute phase of the disease.


Assuntos
Tamponamento Cardíaco , Aneurisma Coronário , Síndrome de Linfonodos Mucocutâneos , Tamponamento Cardíaco/diagnóstico , Tamponamento Cardíaco/etiologia , Criança , Pré-Escolar , Aneurisma Coronário/diagnóstico , Aneurisma Coronário/diagnóstico por imagem , Vasos Coronários/diagnóstico por imagem , Humanos , Lactente , Síndrome de Linfonodos Mucocutâneos/complicações , Síndrome de Linfonodos Mucocutâneos/diagnóstico
2.
Acta Myol ; 40(4): 184-186, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-35047759

RESUMO

Duchenne muscular dystrophy (DMD) is an X-linked myopathy caused by mutations, in most cases deletions and duplications, in the dystrophin gene. Point mutations account for 13% and stop codon mutations are even rarer. Ataluren was approved for the treatment of DMD caused by nonsense mutations in 2014, and several clinical trials documented its efficacy and safety. However, few real-life experience data is available, especially in pediatric age. We report the case of a 2-year- ambulant child affected by DMD caused by the stop-codon mutation c.10801C > T, p.Gln3601X in exon 76, who was early treated with Ataluren at a dosage of 40 mg/kg/die, and presented a rapid improvement in both muscle strength and cognitive and social skills.


Assuntos
Códon sem Sentido , Distrofia Muscular de Duchenne , Criança , Pré-Escolar , Distrofina/genética , Éxons , Humanos , Masculino , Distrofia Muscular de Duchenne/tratamento farmacológico , Distrofia Muscular de Duchenne/genética , Mutação , Oxidiazóis/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA